Table 1.

Demographic, clinical, and treatment characteristics of men evaluated at the JHH PCa MDC, 2008–2012

# of evaluable patients	887
Median age (IQR)	64.0 (58.0, 70.0)
Distance traveled to JHH (miles)
0–200	654 (73.7%)
200–500	104 (11.7%)
500–1000	73 (8.2%)
>1000	56 (6.3%)
ECOG performance status
0	157/166 (94.6%)
1–2	9/166 (5.4%)
Median IPSS (IQR)	7.0 (3.0, 12.0)
Median IIEF (IQR)	20.0 (7.0, 24.0)
Median PSA (IQR)	5.9 (4.4, 9.8)
Chose management at JHH	400 (45.1%)
Management approach
Active surveillance / expectant management	90/698 (12.9%)
Radical prostatectomy	223/698 (32.0%)
EBRT +/− ADT	274/698 (39.3%)
Brachytherapy +/− ADT	43/698 (6.2%)
ADT +/− chemotherapy	47/698 (6.7%)